Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · IEX Real-Time Price · USD
49.57
+0.31 (0.63%)
At close: Jul 19, 2024, 4:00 PM
49.55
-0.02 (-0.04%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for RYTM stock have an average target of 54.33, with a low estimate of 42 and a high estimate of 79. The average target predicts an increase of 9.60% from the current stock price of 49.57.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 8, 2024.
Analyst Ratings
The average analyst rating for RYTM stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $80 → $79 | Strong Buy | Maintains | $80 → $79 | +59.37% | May 8, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $49 → $42 | Strong Buy → Hold | Downgrades | $49 → $42 | -15.27% | May 8, 2024 |
| Needham | Needham | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | -7.20% | May 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +0.87% | Apr 26, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $53 → $52 | Buy | Maintains | $53 → $52 | +4.90% | Apr 18, 2024 |
Financial Forecast
Revenue This Year
125.82M
from 77.43M
Increased by 62.50%
Revenue Next Year
189.70M
from 125.82M
Increased by 50.77%
EPS This Year
-4.53
from -3.20
EPS Next Year
-2.48
from -4.53
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 139.1M | 230.0M | 491.4M | 797.0M | 1.3B |
| Avg | 125.8M | 189.7M | 361.4M | 691.8M | 1.0B |
| Low | 104.4M | 161.4M | 266.4M | 562.6M | 760.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 79.6% | 82.8% | 159.0% | 120.5% | 82.0% |
| Avg | 62.5% | 50.8% | 90.5% | 91.4% | 50.6% |
| Low | 34.8% | 28.3% | 40.5% | 55.7% | 9.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.97 | -1.63 | 1.56 | 5.35 | 11.55 |
| Avg | -4.53 | -2.48 | -0.28 | 3.33 | 7.52 |
| Low | -4.72 | -3.62 | -2.03 | 1.79 | 3.68 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 247.0% |
| Avg | - | - | - | - | 125.9% |
| Low | - | - | - | - | 10.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.